Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Ferrari

Showing results (421-430 of 439) with videos related to

Pageof 44
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
Gene Therapy|November 7, 2007
Progress and prospects: gene therapy clinical trials (part 2)Eric Alton, Stefano Ferrari, Uta Griesenbach, et al.
Cancers|July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint StudyMassimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
BMJ Open Ophthalmology|September 20, 2023
Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocolMatteo Airaldi, Yalin Zheng, Francesco Aiello, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Frontiers in Genetics|October 7, 2024
A proteogenomic atlas of the human neural retinaTabea V Riepe, Merel Stemerdink, Renee Salz, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
BMC Cancer|June 7, 2022
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)David J Barnes, Peter Dutton, Øyvind Bruland, et al.
Pageof 44

Showing results (421-430 of 439) with videos related to

Sort By:
Pageof 44
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
Gene Therapy|November 7, 2007
Progress and prospects: gene therapy clinical trials (part 2)Eric Alton, Stefano Ferrari, Uta Griesenbach, et al.
Cancers|July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint StudyMassimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
BMJ Open Ophthalmology|September 20, 2023
Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocolMatteo Airaldi, Yalin Zheng, Francesco Aiello, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Frontiers in Genetics|October 7, 2024
A proteogenomic atlas of the human neural retinaTabea V Riepe, Merel Stemerdink, Renee Salz, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
BMC Cancer|June 7, 2022
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)David J Barnes, Peter Dutton, Øyvind Bruland, et al.
Pageof 44